Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Entera Bio Ltd. Director's Dealing 2024

Aug 29, 2024

35604_dirs_2024-08-29_3374ca10-2941-469e-aa8e-43f9c641faa3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2024-08-27

Reporting Person: OSTROV GERALD M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-27 Ordinary Shares, par value NIS 0.0000769 per share A 20446 Acquired 30446 Direct